SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 149 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,644,634 | -9.2% | 892,934 | +2.9% | 0.07% | 0.0% |
| Q2 2023 | $22,743,858 | +43.8% | 867,424 | +41.2% | 0.07% | +40.4% |
| Q1 2023 | $15,816,586 | +1.1% | 614,475 | +2.1% | 0.05% | -4.1% |
| Q4 2022 | $15,648,553 | -4.7% | 601,636 | -4.6% | 0.05% | -16.9% |
| Q3 2022 | $16,426,000 | +4.4% | 630,968 | -1.2% | 0.06% | +25.5% |
| Q2 2022 | $15,729,000 | -57.4% | 638,865 | -2.4% | 0.05% | -51.0% |
| Q1 2022 | $36,944,000 | -8.4% | 654,558 | +0.6% | 0.10% | +1.1% |
| Q4 2021 | $40,313,000 | +89.1% | 650,413 | +93.5% | 0.10% | +72.7% |
| Q3 2021 | $21,323,000 | – | 336,102 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |